Cummings Keith Lamont
Insider CIK 1809204 · PLRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 18,198 | — | $0 | 18,198 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 74,250 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 76,200 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 18,198 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 76,047 | — | $0 | 76,047 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 76,047 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 74,250 | — | $0 | 74,250 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 76,200 | — | $0 | 76,200 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 110,500 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 110,500 | — | $0 | 110,500 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 113,300 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 113,300 | — | $0 | 113,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | D To issuer deriv | 2026-04-17 | 2026-04-17 | 124,000 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-04-17 | 2026-04-17 | 124,000 | — | $0 | 124,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2026-01-22 | 2026-01-26 | 400,000 | — | $0 | 400,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2026-01-20 | 2026-01-22 | 24,002 | $1.28 | $30.7K | 297,214 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2025-01-23 | 2025-01-27 | 113,300 | — | $0 | 113,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2025-01-23 | 2025-01-27 | 56,650 | — | $0 | 319,258 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2025-01-17 | 2025-01-22 | 20,148 | $11.20 | $225.7K | 262,608 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-07-10 | 2024-07-12 | 10,911 | $11.56 | $126.1K | 282,115 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-07-09 | 2024-07-11 | 21,313 | — | $0 | 293,026 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2024-05-02 | 2024-05-06 | 21,000 | — | $0 | 76,047 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2024-05-02 | 2024-05-06 | 21,000 | $2.08 | $43.7K | 271,713 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2024-01-23 | 2024-01-24 | 110,500 | — | $0 | 110,500 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2024-01-23 | 2024-01-24 | 55,250 | — | $0 | 249,855 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2024-01-17 | 2024-01-19 | 9,781 | $17.23 | $168.5K | 194,605 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-07-17 | 2023-07-19 | 19,771 | $18.01 | $356.1K | 203,999 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-07-14 | 2023-07-18 | 38,750 | — | $0 | 223,770 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-06-13 | 2023-06-14 | 30,750 | — | $0 | 97,047 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-06-13 | 2023-06-14 | 30,750 | $2.08 | $64.0K | 185,020 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-06-09 | 2023-06-12 | 5,800 | — | $0 | 127,797 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-06-09 | 2023-06-12 | 5,800 | $2.08 | $12.1K | 154,270 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-03-30 | 2023-04-03 | 9,960 | $26.52 | $264.1K | 148,470 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-03-29 | 2023-03-31 | 19,375 | — | $0 | 158,430 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2023-01-25 | 2023-01-27 | 76,200 | — | $0 | 76,200 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2023-01-25 | 2023-01-27 | 54,000 | — | $0 | 138,424 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-23 | 2023-01-25 | 17,500 | — | $0 | 18,198 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2023-01-23 | 2023-01-25 | 12,500 | — | $0 | 133,597 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2023-01-23 | 2023-01-25 | 30,000 | $35.00 | $1.05M | 84,424 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-23 | 2023-01-25 | 12,500 | $2.08 | $26.0K | 96,924 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2023-01-23 | 2023-01-25 | 17,500 | $6.22 | $108.8K | 114,424 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2022-12-22 | 2022-12-27 | 4,000 | — | $0 | 146,097 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2022-12-22 | 2022-12-27 | 4,000 | $2.08 | $8.3K | 84,424 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2022-12-20 | 2022-12-21 | 9,643 | $19.10 | $184.2K | 80,424 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award | 2022-12-19 | 2022-12-21 | 19,375 | — | $0 | 90,067 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2022-01-26 | 2022-02-02 | 124,000 | — | $0 | 124,000 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2021-09-03 | 2021-09-03 | 20,000 | — | $0 | 150,097 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2021-09-03 | 2021-09-03 | 20,000 | $2.08 | $41.6K | 67,621 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2021-03-05 | 2021-03-05 | 20,000 | — | $0 | 170,097 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2021-03-05 | 2021-03-05 | 20,000 | $2.08 | $41.6K | 47,621 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2021-01-23 | 2021-01-26 | 74,250 | — | $0 | 74,250 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2020-12-21 | 2020-12-23 | 4,500 | — | $0 | 190,097 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2020-12-21 | 2020-12-23 | 4,500 | $2.08 | $9.4K | 27,621 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2020-12-01 | 2020-12-02 | 11,591 | — | $0 | 194,597 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2020-12-01 | 2020-12-02 | 7,143 | — | $0 | 35,698 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-01 | 2020-12-02 | 846 | $30.72 | $26.0K | 23,121 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2020-12-01 | 2020-12-02 | 11,591 | $2.08 | $24.1K | 34,712 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-01 | 2020-12-02 | 1,139 | $28.24 | $32.2K | 40,716 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-01 | 2020-12-02 | 1,848 | $29.07 | $53.7K | 38,868 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | S Sale | 2020-12-01 | 2020-12-02 | 14,901 | $30.21 | $450.2K | 24 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2020-12-01 | 2020-12-02 | 7,143 | $6.22 | $44.4K | 41,855 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion deriv | 2020-06-05 | 2020-06-09 | 27,322 | — | $0 | 0 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | C Conversion | 2020-06-05 | 2020-06-09 | 3,821 | — | $0 | 23,121 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise deriv | 2020-04-30 | 2020-06-09 | 19,300 | — | $0 | 206,188 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | M Exercise | 2020-04-30 | 2020-06-09 | 19,300 | $2.08 | $40.1K | 19,300 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2020-03-31 | 2020-06-09 | 42,841 | — | $0 | 42,841 | SEC↗ |
| PLRX PLIANT THERAPEUTICS, INC. | A Award deriv | 2020-02-28 | 2020-06-09 | 27,322 | $13.08 | $357.4K | 27,322 | SEC↗ |